[Therapy of systemic lupus erythematosus and of pseudo-le-syndrome].
D000368:Aged; D001379:Azathioprine / Q000627:therapeutic use; D002738:Chloroquine / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D003937:Diagnosis, Differential; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D010653:Phenylbutazone / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D012459:Salicylates / Q000627:therapeutic use; D012737:Sex Factors; D013577:Syndrome
D005938:Glucocorticoids; D012459:Salicylates; D002738:Chloroquine; D003520:Cyclophosphamide; D010653:Phenylbutazone; D001379:Azathioprine; D011241:Prednisone; D007213:Indomethacin; D008727:Methotrexate
Therapie des systemischen Lupus erythematodes und des Pseudo-LE-Syndroms.